SanBio Company Limited
SNBIF
$16.45
$2.1715.20%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -33.61% | -15.37% | -15.37% | -11.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -56.53% | -53.27% | -53.27% | -45.80% |
| Operating Income | -- | 56.53% | 53.27% | 53.27% | 45.80% |
| Income Before Tax | -- | 71.61% | 76.87% | 76.87% | 47.06% |
| Income Tax Expenses | -- | 142.97% | 188.96% | 188.96% | -91.99% |
| Earnings from Continuing Operations | -- | 62.87% | 65.53% | 65.53% | 54.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 62.87% | 65.53% | 65.53% | 54.87% |
| EBIT | -- | 56.53% | 53.27% | 53.27% | 45.80% |
| EBITDA | -- | 56.42% | 53.17% | 53.17% | 45.49% |
| EPS Basic | -- | 65.26% | 68.05% | 68.05% | 58.59% |
| Normalized Basic EPS | -- | 70.57% | 75.74% | 75.74% | 43.28% |
| EPS Diluted | -- | 65.26% | 68.05% | 68.05% | 58.59% |
| Normalized Diluted EPS | -- | 70.57% | 75.74% | 75.74% | 43.28% |
| Average Basic Shares Outstanding | -- | 6.90% | 8.85% | 8.85% | 12.78% |
| Average Diluted Shares Outstanding | -- | 6.90% | 8.85% | 8.85% | 12.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |